Makers Laboratories is currently trading at Rs. 221.00, up by 7.85 points or 3.68% from its previous closing of Rs. 213.15 on the BSE.
The scrip opened at Rs. 215.00 and has touched a high and low of Rs. 222.00 and Rs. 215.00 respectively. So far 1844 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 344.80 on 05-Feb-2021 and a 52 week low of Rs. 107.05 on 11-Nov-2020.
Last one week high and low of the scrip stood at Rs. 219.00 and Rs. 200.00 respectively. The current market cap of the company is Rs. 104.81 crore.
The promoters holding in the company stood at 58.37%, while Non-Institutions held 41.63% stake in the company.
Makers Laboratories has received an approval to raise further capital by the issuance of equity shares of face value of Rs 10 each of the company on rights basis to the eligible equity shareholders of the company as on the record date, of an issue size of about Rs 14.75 crore.
The proceeds of the issue will be utilized primarily for upgrading/capacity enhancement of the company's old injectable manufacturing unit situated at Naroda, Ahmedabad. The Board of Directors of the company, at its meeting held on November 10, 2021 has approved the same.
Makers Laboratories is engaged in manufacturing pharmaceutical formulations and drug intermediaries. The product portfolio of the company includes Tablets & Capsules,Liquids (Oral),Injectables,Drugs (Intermediates)and Creams & Ointments.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1673.40 |
| Dr. Reddys Lab | 1216.15 |
| Cipla | 1224.70 |
| Zydus Lifesciences | 932.50 |
| Lupin | 2345.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: